Prescription Project Says DTC Ads Violate FDA Rules

• FDA cGMP QSR GMP Training - online training classes taught by SkillsPlus International Inc.

Updated October 18, 2020

The link in the original post broke.

You might also like:

REFILE-Medical devicemakers adopt voluntary U.S. ad rules - Reuters

- - -  the original post follows below

Personally, I dislike direct to consumer (DTC) ads for myriad reasons that I won't go into. I digress. Here's the real news. A consumer watchdog group, The Prescription Project, questioned the legality of several advertisements for medical devices that appear on YouTube, and they want regulators to crack down on the promotions. The Project claims, DTC advertisements for several medical devices on the video Web site YouTube violate federal regulations because they don't include required warnings and disclosures about potential risks. They cite ads for Abbott's Xience V, a drug-coated stent; Medtronic's Prestige Cervical Disc, a spinal implant; Stryker's Cormet hip-resurfacing system; and they want the ads removed from YouTube. The Project's policy director states, "The videos raise serious questions about whether drug and device companies are using the Internet to skirt laws that safeguard consumers." The FDA has roughly six months to respond to the Project's petition. For a super concise briefing, read this quick read on the Pharma 2.0 blog, "Prescription Project targets medtech ads on YouTube." 

Return Home: The Health, Drug, Prescription, and GMP Supersite Blog

SkillsPlus Intl Inc. - The best GMP training, best QSR training, best instructors
Designated Rep Certification Class
CA Designated Representative Training Program
California Designated Representative Training Program
California HMDR Exemptee Training
Exemptee Certification Class
FL CDR Exam Prep
SkillsPlus Intl Inc. - The Leader in Compliance Training
The Health, Drug, Prescription, and GMP Supersite Gift Store